Iovance Biotherapeutics Inc. (IOVA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Iovance Biotherapeutics I...

    NASDAQ: IOVA · Real-Time Price · USD
    2.34
    0.09 (4.00%)
    At close: Oct 03, 2025, 3:59 PM
    2.35
    0.43%
    After-hours: Oct 03, 2025, 07:56 PM EDT

    Iovance Biotherapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -372.18M -444.04M -395.89M -342.25M
    Depreciation & Amortization
    		 43.61M 33.13M 21.14M 13.98M
    Stock-Based Compensation
    		 109.63M 62.63M 84.02M 69.77M
    Other Working Capital
    		 -5.61M -1.08M -8.78M 17.58M
    Other Non-Cash Items
    		 -8.65M -3.54M 871K 6.01M
    Deferred Income Tax
    		 -2.83M -3.48M n/a n/a
    Change in Working Capital
    		 -122.56M -6.52M -2.89M 24.55M
    Operating Cash Flow
    		 -352.98M -361.82M -292.76M -227.94M
    Capital Expenditures
    		 -11.07M -22.29M -20.43M -37.57M
    Cash Acquisitions
    		 -52.57M -212.63M -276.88M -37.71M
    Purchase of Investments
    		 -460.77M -205.9M -245.82M -725.21M
    Sales Maturities Of Investments
    		 428M 285.58M 522.7M 762.91M
    Other Investing Acitivies
    		 n/a n/a 276.88M 37.71M
    Investing Cash Flow
    		 -96.41M -155.24M 256.45M 132K
    Debt Repayment
    		 n/a n/a n/a 1M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -6.64M -322K 648K 35.11M
    Financial Cash Flow
    		 390.66M 462.96M 190.15M 239.27M
    Net Cash Flow
    		 -59.27M -56.84M 153.85M 11.46M
    Free Cash Flow
    		 -364.05M -384.11M -313.18M -265.51M

    Add to Watchlist